Eighteen Month Oral Study of Aspirin, Phenacetin and Caffeine in C57BL/6 Mice

References

• Anon. Headache Cures. The Lone Hand (1907); 2: 193
   Google Scholar
• Grimlund K. Phenacetin and renal damage at a Swedish factory. Acta Med. Scand. (1963), Suppl. 405: 1
   PubMedGoogle Scholar
• Spühler O., Zollinger H. U. Die chronischinterstitielle Nephritis. Z. Klin. Med. (1953); 151: 1
   PubMedGoogle Scholar
• Shelley J. H. Phenacetin through the looking glass. Clin. Pharmacol. Ther. (1967); 8: 427
   PubMed Web of Science ®Google Scholar
• Abel J. A. Analgesic Nephropathy‐A review of the literature, 1967–1970. Clin. Pharmacol. Ther. (1971); 112: 583
   Google Scholar
• Nanra R. S., Kincaid‐Smith P. Chronic effect of analgesics on the kidney. Progr. Biochem. Pharmacol. (1972); 7: 285
   PubMedGoogle Scholar
• Rosner I. Experimental analgesic nephropathy. Crit. Rev. Toxicol. (1976); 4: 331
   Web of Science ®Google Scholar
• Carro‐Ciampi G. Phenacetin abuse: A review. Toxicology (1978); 10: 311
   PubMed Web of Science ®Google Scholar
• Prescott L. F. Analgesic nephropathy‐the international experience. Aust. N.Z.J. Med. (1976), Suppl. 1: 44, 6
   Google Scholar
• Kincaid‐Smith P. Analgesic nephropathy. Kidney Int. (1978); 13: 1
   PubMed Web of Science ®Google Scholar
• Nanra R. S., Stuart‐Taylor J., DeLeon A. H., White K. H. Analgesic nephropathy: Etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int. (1978); 13: 79
   PubMed Web of Science ®Google Scholar
• Dubach U. C. Nephropathies due to Analgesics. Contrib. Nephrol. (1978); 10: 75
   PubMedGoogle Scholar
• Kincaid‐Smith P. Analgesic nephropathy, A common form of renal disease in Australia. Med. J. Aust. (1969); 2: 1131
   PubMed Web of Science ®Google Scholar
• Burry A. F. The evolution of analgesic nephropathy. Nephron (1967); 5: 185
   Google Scholar
• Clausen E. Histological changes in rabbit kidneys induced by phenacetin and acetylsalicylic acid. Lancet (1964); 2: 123
   PubMed Web of Science ®Google Scholar
• Fordham C. C., Huffines W. C., Welt L. G. Phenacetin‐induced renal disease in rats. Ann. Intern. Med. (1965); 62: 738
   PubMed Web of Science ®Google Scholar
• Abrahams C., Rubenstein A. H., Levin N. W., Wunderlich U. Experimentally induced analgesic nephritis in rats. Arch. Pathol. (1964); 78: 222
   PubMedGoogle Scholar
• Saker B. M., Kincaid‐Smith P. Papillary necrosis in experimental analgesic nephropathy. Br, Med. J. (1969); 1: 161
   PubMed Web of Science ®Google Scholar
• Nanra R. S., Kincaid‐Smith P. Papillary necrosis in rats caused by aspirin and aspirin‐containing mixtures. Br. Med. J. (1970); 3: 559
   PubMed Web of Science ®Google Scholar
• Nanra R. S. Pathology, aetiology and pathogenesis of analgesic nephropathy. Aust. N.Z. J. Med. (1974); 4: 602
   Google Scholar
• Axelsen R. A. Analgesic‐induced renal papillary necrosis in the Gunn rat: The comparative nephrotoxicity of aspirin and phenacetin. J. Pathol. (1976); 120: 145
   PubMed Web of Science ®Google Scholar
• Brown D. M., Hardy T. L. Short‐term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br. J. Pharmacol. Chemother. (1968); 32: 17
   PubMed Web of Science ®Google Scholar
• Nanra R. S., Chirawong P., Kincaid‐Smith P. Renal papillar necrosis in rats produced by aspirin, A.P.C., and other analgesics. Renal Infection and Renal Scarring, P. Kincaid‐Smith, K. F. Fairley. Melbourne, Mercedes Publ. Service, Melbourne (1970); 347
   Google Scholar
• Arnold L., Collins C., Starmer G. A. Renal and gastric lesions after phenylbutazone and indomethacin in the rat. Pathology (1974); 6: 303
   PubMed Web of Science ®Google Scholar
• Bokelman D. L., Bagdon W. J., Mattis P. A., Stonier P. F. Strain‐dependent renal toxicity of a nonsteroid anti‐inflammatory agent. Toxicol. Appl. Pharmacol. (1971); 19: 111
   PubMed Web of Science ®Google Scholar
• Wiseman E. H., Reinert H. Anti‐inflammatory drugs and renal papillary necrosis. Agents Actions (1975); 5: 322
   PubMedGoogle Scholar
• Hardy T. L. N‐phenyl anthranilic acid: An agent for inducing and studying renal papillary necrosis in the rat. Br. J. Exp. Pathol. (1970); 51: 348
   PubMed Web of Science ®Google Scholar
• Ennnerson J. L., Gibson W. R., Pierce E. C., Todd G. C. Preclinical Toxicology of Fenoprofen. Toxicol. Appl. Pharmacol. (1973); 25: 444
   Web of Science ®Google Scholar
• Hultengren N., Lagergren C., Ljungqvist A. Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir. Scand. (1965); 130: 314
   PubMedGoogle Scholar
• Taylor J. S. Carcinoma of the urinary tract and analgesic abuse. Med. J. Aust. (1972); 1: 407
   PubMed Web of Science ®Google Scholar
• Juusela H. Carcinoma of the renal pelvis and its relationship to analgesic abuse. Ann. Chir. Gynaecol. Fenn. (1973); 62: 386
   PubMedGoogle Scholar
• Moshakis V., Hooper A. A. Analgesic nephropathy and transitional cell carcinoma. Postgrad. Med. J. (1978); 54: 285
   PubMed Web of Science ®Google Scholar
• Küng L. G. Hypernephroides karzinom und karzinome der ableitenden harnwege nach phenacetinabusus. Schweiz. Med. Wochenschr. (1976); 106: 47
   PubMedGoogle Scholar
• Bock K. D., Hogrefe J. Analgetika‐abusus und maligne tumoren der ableitenden harnwege. Muench. Med. Wochenschr. (1972); 114: 645
   PubMedGoogle Scholar
• Liu T., Smith G. W., Rankin J. T. Renal pelvic tumour associated with analgesic abuse. Can. Med. Assoc. J. (1972); 107: 768
   PubMed Web of Science ®Google Scholar
• Høbye G., Nielsen O. E. Renal pelvic carcinoma in phenacetin abusers. Scand. J. Urol. Nephrol. (1971); 5: 190
   PubMedGoogle Scholar
• Lornoy W., Morelle V., Becaus I., Fonteyne E., Vrouwziekenhuis O. L. Letter to Editor. N. Engl. J. Med. (1979); 300: 319
   PubMedGoogle Scholar
• Bengtsson U., Johansson S., Angervall L. Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int. (1978); 13: 107
   PubMed Web of Science ®Google Scholar
• Welch R. M., Gillispie D. D. A method for Determining 2‐Hydroxyphenetidine in the Urine of Mice Following Treatment with Acetophenetidine. Pharmacologist (1971); 13: 295
   Google Scholar
• Calder I. e., Funder C. C., Green C. R., Ham K. N., Tange J. D. Comparative nephrotoxicity of aspirin and phenacetin derivatives. Br. Med. J. (1971); 4: 518
   PubMed Web of Science ®Google Scholar
• Stevenson G. W. Rapid Ultraviolet Spectrophotometric Determination of Salicylate in Blood. Anal. Chem. (1960); 32: 1522
   Web of Science ®Google Scholar
• Bratton A. C., Marshall E. K., Jr. A New Coupling Component For Sulfanilamide Determination. J. Biol. Chem. (1939); 128: 537
   Google Scholar
• Beutler E. Methemoglobin and sulfhemoglobin determination. Hematology, W. J. Williams, E. Beutler, A. Erslev, R. W. Rundles. McGraw‐Hill, New York (1972); 1381
   Google Scholar
• Calder I. C., Goss D. E., Williams P. J., Funder C. C., Green C. R., Ham K. N., Tange J. D. Neoplasia in the rat induced by N‐OHP, a metabolite of phenacetin. Pathology. (1976); 8: 1
   PubMed Web of Science ®Google Scholar
• Frith C. H. Personal Communication. 1976
   Google Scholar
• Squire R. A., Levitt M. H. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. (1975); 35: 3214
   PubMed Web of Science ®Google Scholar
• Bioassay of a mixture of Aspirin, Phenacetin and Caffeine for Possible Carcinogenicity. NCI Technical Report Series No. 67, National Cancer Institute, Bethesda 1978
   Google Scholar
• Woodard G., Post K. F., Cockrell K. O., Cronin M. T.I. Phenacetin: Long‐term studies in rats and dogs. Toxicol. Appl. Pharmacol. (1965); 7: 503
   Web of Science ®Google Scholar
• Schmähl D., Reiter A. Fehlen einer cancerogenen Wirkung beim phenacetin. Azneim. Forsch. (1954); 4: 404
   PubMed Web of Science ®Google Scholar
• Studer A., Scharer K. Langtristige phenacetin belastung am hund mit berücksichtigung der leberund nierenpigmentie‐rung. Schweiz. Med. Wochenschr. (1965); 95: 933
   PubMedGoogle Scholar
• Bioassay of 4‐(chloroacetyl)‐acetanilide for Possible Carcinogenicity. NCI Technical Report Series No. 177, National Cancer Institute, Bethesda
   Google Scholar
• Bengtsson U. Phenacetin and renal pelvic carcinoma. Clin. Nephrol. (1974); 2: 123
   PubMed Web of Science ®Google Scholar
• Johansson S., Angervall L. Urothelial changes of the renal papillae in Sprague‐Dawley rats induced by long term feeding of phenacetin. Acta Pathol. Microbiol. Scand. Sect. A. (1976); 84: 375
   PubMedGoogle Scholar
• Isaka H., Yoshii H., Otsuji A., Koike M., Nagai Y., Koura M., Sugiyasu K., Kanabayashi T. Tumors of Sprague‐Dawley rats induced by long term feeding of phenacetin. Gann (1979); 70: 29
   PubMedGoogle Scholar
• Johansson S., Angervall L. Letter to Editior. Science (1979); 204: 130
   PubMedGoogle Scholar
• Wornick R. C. Feed pelleting and its effects on microingredients. Lecture Series No. 6 Agricultural Research and Development Department, Chas. Pfizer and Co., Inc., Terre Haute, Ind. 1959
   Google Scholar
• Hudson J. O. California Pellet Mill Company. Personal Communication. 1979
   Google Scholar
• Kurokawa Y. Personal Communication. National Institute of Hygienic Sciences, Tokyo 1979
   Google Scholar
• Turusov V. S. Pathology of Tumors of Laboratory Animals. IARC Scientific Publications No. 6, International Agency for Research on Cancer, Lyon 1976
   Google Scholar
• Bioassay of 1, 4‐Dioxane for Possible Carcinogenicity. NCI Technical Report Series No. 80, National Cancer Institute, Bethesda 1978
   Google Scholar
• Magee P. N., Montesano R., Preussmann R. N‐nitroso compounds and related carcinogens. Chemical Carcinogens, C. E. Searle. ACS Monograph 173, American Chemical Society, Washington, D.C. (1976); 491
   Google Scholar
• International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 17: Some n‐Nitroso compounds. IARC, Lyon 1978
   Google Scholar
• Bertram J. S., Craig A. W. Induction of Bladder Tumours in Mice with Dibutylnitrosamine. Br. J. Cancer (1970); 24: 352
   PubMed Web of Science ®Google Scholar
• Bertram J. S., Craig A. W. Specific Induction of Bladder Cancer in Mice by Butyl‐(4‐hydroxybutyl)‐Nitrosamine and the Effects of Hormonal Modifications on the Sex Difference in Response. Eur. J. Cancer (1972); 8: 587
   PubMed Web of Science ®Google Scholar
• Ito N., Hiasa Y., Kamamoto Y., Makiura S., Sugihara S., Marugami M., Okajima E. Histopathological analysis of kidney tumors in rats induced by chemical carcinogens. Gann (1971); 62: 435
   PubMedGoogle Scholar
• Lijinsky W. H.R. Hearings Regulation of Food Additive and Medicated Animal Feeds. 92nd Congress. U.S. Govt. Printing Office, Washington (1971); 8
   Google Scholar
• Eisenbrand G., Preussmann R. Nitrosation of phenacetin. Arzneim. Forsch. (1975); 15: 1472
   Google Scholar
• Klutch A., Bordun M. Chromatographic methods for analysis of the metabolites of acetophenetidin. J. Pharm. Sci. (1968); 57: 524
   PubMed Web of Science ®Google Scholar
• Nery R. Some new aspects of the metabolism of phenacetin in the rat. Biochem. J. (1971); 122: 317
   PubMed Web of Science ®Google Scholar
• Ziegler D. M., McKee E. M., Poulsen L. L. Microsomal flavoprotein‐catalyzed N‐oxidation of arylamines. Drug Metab. Dispos. (1973); 1: 314
   PubMed Web of Science ®Google Scholar